| mRNA |
ABT-263 |
CTRPv2 |
pan-cancer |
AAC |
0.23 |
5e-10 |
| mRNA |
nelarabine |
CTRPv2 |
pan-cancer |
AAC |
0.23 |
1e-08 |
| mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.22 |
1e-08 |
| mRNA |
ABT-199 |
CTRPv2 |
pan-cancer |
AAC |
0.25 |
3e-08 |
| mRNA |
ABT-737 |
CTRPv2 |
pan-cancer |
AAC |
0.21 |
5e-08 |
| mRNA |
navitoclax:PLX-4032 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
2e-07 |
| mRNA |
barasertib |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
2e-07 |
| mRNA |
navitoclax:piperlongumine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.2 |
3e-07 |
| mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
5e-07 |
| mRNA |
navitoclax:sorafenib (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
2e-06 |